BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30276310)

  • 1. Targeting G protein-coupled receptor for pain management.
    Li H; Wang R; Lu Y; Xu X; Ni J
    Brain Circ; 2017; 3(2):109-113. PubMed ID: 30276310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential.
    Jiang BC; Liu T; Gao YJ
    Pharmacol Ther; 2020 Aug; 212():107581. PubMed ID: 32450191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain.
    Szabo I; Chen XH; Xin L; Adler MW; Howard OM; Oppenheim JJ; Rogers TJ
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10276-81. PubMed ID: 12130663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutively active chemokine CXC receptors.
    Han X
    Adv Pharmacol; 2014; 70():265-301. PubMed ID: 24931199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines as pain mediators and modulators.
    White FA; Wilson NM
    Curr Opin Anaesthesiol; 2008 Oct; 21(5):580-5. PubMed ID: 18784482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterophilic chemokine receptor interactions in chemokine signaling and biology.
    Kramp BK; Sarabi A; Koenen RR; Weber C
    Exp Cell Res; 2011 Mar; 317(5):655-63. PubMed ID: 21146524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of tolerance to chemokine receptor antagonists: current paradigms and the need for further investigation.
    Grudzien P; Neufeld H; Ebe Eyenga M; Gaponenko V
    Front Immunol; 2023; 14():1184014. PubMed ID: 37575219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.
    Lee HJ; Song IC; Yun HJ; Jo DY; Kim S
    World J Gastroenterol; 2014 Feb; 20(7):1681-93. PubMed ID: 24587647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain.
    Pawlik K; Mika J
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells.
    Brack A; Rittner HL; Machelska H; Leder K; Mousa SA; Schäfer M; Stein C
    Pain; 2004 Dec; 112(3):229-238. PubMed ID: 15561377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
    Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M
    Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of chemokine activity by posttranslational modification.
    Mortier A; Van Damme J; Proost P
    Pharmacol Ther; 2008 Nov; 120(2):197-217. PubMed ID: 18793669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy.
    Bogacka J; Pawlik K; Ciapała K; Ciechanowska A; Mika J
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.
    Shimaoka T; Nakayama T; Fukumoto N; Kume N; Takahashi S; Yamaguchi J; Minami M; Hayashida K; Kita T; Ohsumi J; Yoshie O; Yonehara S
    J Leukoc Biol; 2004 Feb; 75(2):267-74. PubMed ID: 14634054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells.
    Gouwy M; Struyf S; Leutenez L; Pörtner N; Sozzani S; Van Damme J
    Immunobiology; 2014 Mar; 219(3):218-29. PubMed ID: 24268109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain.
    Vincenzi M; Milella MS; D'Ottavio G; Caprioli D; Reverte I; Maftei D
    Life (Basel); 2022 Mar; 12(3):. PubMed ID: 35330149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic assessment of chemokine ligand bias at the human chemokine receptor CXCR2 indicates G protein bias over β-arrestin recruitment and receptor internalization.
    Boon K; Vanalken N; Szpakowska M; Chevigné A; Schols D; Van Loy T
    Cell Commun Signal; 2024 Jan; 22(1):43. PubMed ID: 38233929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine-immune interaction: regulation of inflammation via G-protein coupled receptors.
    Verburg-van Kemenade BM; Van der Aa LM; Chadzinska M
    Gen Comp Endocrinol; 2013 Jul; 188():94-101. PubMed ID: 23201149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum amyloid A1α induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils.
    De Buck M; Berghmans N; Pörtner N; Vanbrabant L; Cockx M; Struyf S; Opdenakker G; Proost P; Van Damme J; Gouwy M
    J Leukoc Biol; 2015 Dec; 98(6):1049-60. PubMed ID: 26297794
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.